Trump says tariffs on South Korean autos, pharma, to rise to 25% over trade deal approval delay

CNBC Published Updated Stocks
Sign in to save

Why it matters

US President Trump has announced a 25% tariff increase on South Korean autos and pharma imports, citing a delay in trade deal approval, which may impact Hyundai Motor's US sales and other affected companies.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Bearish Confidence 80% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on bearish sentiment with 80% confidence.

Evidence trail

Evidence
Source CNBC
Claim Trump says tariffs on South Korean autos, pharma, to rise to 25% over trade deal approval delay
AI inference Bearish · 80%
Generated 2026-01-26 22:14

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
37414

Original source

South Korean-based automaker Hyundai Motor is the largest importer of new vehicles from that country into the United States.

Read the full article on CNBC

Original article published by CNBC on January 27, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage